No, I was being glib about the fact that they appeared to have had very significant funding and yet ran a study that had several fairly major weaknesses (I.e. unrandomized) when it would've been just as easy to do it right
-
-
But all of this comes back to a really rigorous RCT! If we had such results, and cost data, we could know exactly how effective Virta is compared to the next best treatment Alas, we don't have this information, which is a big issue
-
Has anyone looked at cost effectiveness as it related to CSIRO study? Seems that could give a satisfactory answer with regards to cost savings from med reductions in the low carb arm.
- Show replies
New conversation -
-
-
I see where you are coming from.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.